Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PNC vs GSK✓SelectedUSD · GSKPNC vs GSK performance historyLatest closeAs of+0.55%11/13
Stock and ETF performance explorer

PNC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+3,837.3%
GSK return
+1,742.6%
Excess return
+2,094.7%
Maximum drawdown
-76.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.5%+0.5%0.0%+0.4%
7D+3.1%+1.1%+1.9%+2.7%
30D+7.6%+6.3%+1.3%+5.2%
3M-8.1%+1.8%-10.0%-9.1%
6M+12.6%+1.7%+10.9%+11.2%
YTD+15.0%+6.5%+8.4%+11.1%
1Y+30.4%+9.5%+20.9%+24.7%
3Y+116.1%+65.3%+50.8%+72.4%
5Y+37.5%+43.7%-6.3%+13.9%
10Y+205.1%+104.1%+101.0%+119.5%
All+3,837.3%+1,742.6%+2,094.7%+1,313.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling